CD38 and cancer: Next, we focused on the potential role of IL-33-responsive CD8Low and CD8High T lymphocytes during nutrient deprivation by analyzing cell surface markers such as the adenosine-converting ectoenzymes CD38 and CD39, which have been proposed as targets for cancer immunotherapy.